These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1888264)

  • 1. Biochemical mechanism of caffeine tolerance.
    Ammon HP
    Arch Pharm (Weinheim); 1991 May; 324(5):261-7. PubMed ID: 1888264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of adenosine receptors in caffeine tolerance.
    Holtzman SG; Mante S; Minneman KP
    J Pharmacol Exp Ther; 1991 Jan; 256(1):62-8. PubMed ID: 1846425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose adenosine overcomes the attenuation of myocardial perfusion reserve caused by caffeine.
    Reyes E; Loong CY; Harbinson M; Donovan J; Anagnostopoulos C; Underwood SR
    J Am Coll Cardiol; 2008 Dec; 52(24):2008-16. PubMed ID: 19055993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral characterization of caffeine and adenosine agonists during chronic caffeine exposure.
    Newland MC; Brown K
    Behav Pharmacol; 1997 Feb; 8(1):17-30. PubMed ID: 9832997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caffeine and sports activity: a review.
    Nehlig A; Debry G
    Int J Sports Med; 1994 Jul; 15(5):215-23. PubMed ID: 7960313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caffeine exposure alters adenosine system and neurochemical markers during retinal development.
    Brito R; Pereira-Figueiredo D; Socodato R; Paes-de-Carvalho R; Calaza KC
    J Neurochem; 2016 Aug; 138(4):557-70. PubMed ID: 27221759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caffeine tolerance: behavioral, electrophysiological and neurochemical evidence.
    Chou DT; Khan S; Forde J; Hirsh KR
    Life Sci; 1985 Jun; 36(24):2347-58. PubMed ID: 2989634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic treatment with caffeine blunts the hyperlocomotor but not cognitive effects of the N-methyl-D-aspartate receptor antagonist MK-801 in mice.
    Dall'Igna OP; Da Silva AL; Dietrich MO; Hoffmann A; de Oliveira RV; Souza DO; Lara DR
    Psychopharmacology (Berl); 2003 Mar; 166(3):258-63. PubMed ID: 12589526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-tolerance studies between caffeine and (-)-N6-(phenylisopropyl)-adenosine (PIA) in mice.
    Ahlijanian MK; Takemori AE
    Life Sci; 1986 Feb; 38(7):577-88. PubMed ID: 3003486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of adenosinergic receptor system in an animal model of tardive dyskinesia and associated behavioural, biochemical and neurochemical changes.
    Bishnoi M; Chopra K; Kulkarni SK
    Eur J Pharmacol; 2006 Dec; 552(1-3):55-66. PubMed ID: 17064683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caffeine and coffee tolerance.
    Notarius CF; Rongen GA; Floras JS
    Circulation; 2003 Aug; 108(6):e38-40; author reply e38-40. PubMed ID: 12914013
    [No Abstract]   [Full Text] [Related]  

  • 12. Dose-dependent surmountability of locomotor activity in caffeine tolerance.
    Lau CE; Falk JL
    Pharmacol Biochem Behav; 1995 Sep; 52(1):139-43. PubMed ID: 7501656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caffeine-mediated induction of c-fos, zif-268 and arc expression through A1 receptors in the striatum: different interactions with the dopaminergic system.
    Dassesse D; Vanderwinden JM; Goldberg I; Vanderhaeghen JJ; Schiffmann SN
    Eur J Neurosci; 1999 Sep; 11(9):3101-14. PubMed ID: 10510174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of (-)-N6-(R-phenylisopropyl)-adenosine (PIA) and caffeine on nociception and morphine-induced analgesia, tolerance and dependence in mice.
    Ahlijanian MK; Takemori AE
    Eur J Pharmacol; 1985 Jun; 112(2):171-9. PubMed ID: 2992993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caffeine and exercise performance. An update.
    Dodd SL; Herb RA; Powers SK
    Sports Med; 1993 Jan; 15(1):14-23. PubMed ID: 8426941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiovascular effects of everyday coffee consumption].
    Bättig K
    Schweiz Med Wochenschr; 1992 Oct; 122(41):1536-43. PubMed ID: 1411413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xanthine derivatives in the heart: blessed or cursed?
    Szentmiklósi AJ; Cseppentō A; Gesztelyi R; Zsuga J; Körtvély A; Harmati G; Nánási PP
    Curr Med Chem; 2011; 18(24):3695-706. PubMed ID: 21774759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of caffeine on the cholinergic system.
    Pohanka M
    Mini Rev Med Chem; 2014; 14(6):543-9. PubMed ID: 24873820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caffeine and other sympathomimetic stimulants: modes of action and effects on sports performance.
    Jones G
    Essays Biochem; 2008; 44():109-23. PubMed ID: 18384286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonism of the cardiovascular effects of adenosine by caffeine or 8-(p-sulfophenyl)theophylline.
    Evoniuk G; von Borstel RW; Wurtman RJ
    J Pharmacol Exp Ther; 1987 Feb; 240(2):428-32. PubMed ID: 3806407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.